Streetbeat News

Products Services

AZN

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for AstraZeneca's Omjjara for the treatment of Myelofibrosis. The article does not mention GSK or VGK.

Portfolio Pulse from Charles Gross

November 10, 2023 | 12:21 pm

AKTS

Akoustis Technologies has received a purchase order for three BAW filter designs from a customer in the 5G mobile and Wi-Fi router RF front-end market. The company's stock symbol is AKTS.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:08 pm

AAOI

Applied Optoelectronics has entered into an exclusive distribution agreement with Digicomm International. Under the agreement, Digicomm will be the exclusive go-to-market supplier of AOI's Quantum12 Cable Amplifiers.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:07 pm

KZIA

Kazia Therapeutics has announced the publication of preclinical data on Paxalisib, a product of its research collaboration with the Huntsman Cancer Institute at the University of Utah. The data, published in Molecular Cancer Therapeutics, highlights the potential of Paxalisib in cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:06 pm

LILM

Lilium N.V. (NASDAQ:LILM) has extended its partnership with InoBat for high-volume production of the Lilium Jet's high-performance battery cells. This move is part of Lilium's multiple-sourcing strategy for cell production and will help secure a steady supply of battery cells for the Lilium Jet.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:05 pm

BCRX

BioCryst Pharmaceuticals has released new real-world data showing reduced attack rates in patients with Hereditary Angioedema (HAE) with normal C1-inhibitor following long-term treatment with ORLADEYO (berotralstat).

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:04 pm

MAIA

The FDA has granted Orphan Drug Designation to MAIA Biotechnology's lead asset THIO, a cancer telomere-targeting agent, for the treatment of Glioblastoma.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:03 pm

INAB

IN8bio, Inc. (NASDAQ:INAB) will present two posters at the Society for Neuro-Oncology (SNO) 28th Annual Meeting, highlighting the potential of its DeltEx Drug Resistant Immunotherapy (DRI) to treat patients with newly diagnosed glioblastoma multiforme (GBM). The posters will detail the study design for INB-400, the company-sponsored Phase 2 trial, and provide updated clinical data from the Phase 1 INB-200 trial.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 12:02 pm

BTCUSD

DOGEUSD

FLOKIUSD

SHIBUSD

Bitcoin's price is rallying, surpassing $35,000, driven by interest in Bitcoin Spot ETFs and anticipation of the 2024 halving. Gracy Chen, CEO of Bitget, believes the Federal Reserve’s interest rates and the introduction of spot BTC ETFs could heavily influence the BTC price. She also expressed skepticism about Ark Invest CEO Cathie Wood’s prediction of BTC reaching $1 million by 2030, but believes $100,000 is feasible. Bitget has grown to 1,500 employees and its copy trading product has been successful. Chen also expressed interest in layer two solutions and various tokens ranked between 100 to 1,000 market cap.

Portfolio Pulse from Mehab Qureshi

November 10, 2023 | 11:58 am

PL

Planet Labs (NYSE:PL) announced that its Pelican tech demonstration satellite, Pelican-1, and 36 SuperDoves, Flock 4Q, will be launched on SpaceX's Transporter-9 mission on November 11, 2023. The mission will validate the design and operations of Planet's common bus platform, which will host Planet's next generation of imaging sensors. Planet's shares closed lower by 3.67% at $2.10 on Thursday.

Portfolio Pulse from Shivani Kumaresan

November 10, 2023 | 11:27 am